CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma

Hongwen Li(Anhui Medical University), Mingzhi Zhang(Chinese Academy of Sciences), Jiazhuo Wu(Zhengzhou University), Wenting Song(Huazhong Agricultural University), Lijuan Han(Centre National de la Recherche Scientifique), Yong Li(Baylor College of Medicine), J Y Li(Fudan University Shanghai Cancer Center), Jianxiang Zhang(Renmin University of China), Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Yuyang Gao(Zhengzhou University), Zhuangzhuang Shi(First Affiliated Hospital of Zhengzhou University)
BMC Medicine
August 30, 2023
10.1186/s12916-023-03040-0
Cited by 20

Related Papers

Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
|Molecular Cancer|2020|578
Circular RNAs in human cancer
|Molecular Cancer|2017|527